Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI platform that creates and streamlines regulatory documentation across diagnostic, medical-device, and drug development.
Collate, founded in 2024 and headquartered in San Francisco, California, builds an AI platform that creates and streamlines regulatory and technical documentation for diagnostic, medical-device, and drug-development companies across the product lifecycle. The company reports roughly $125M raised, including a 2026 Series A led by Redpoint Ventures. Atlas found no vendor-held security certifications documented on its public site; generated documents are AI drafts requiring expert review before submission.
57% — Partial coverage. Coverage score — how completely Atlas documents Collate across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, Top 20 Pharma, Regulatory Affairs, R&D Leadership
Natural Language Processing, Regulatory Submission Authoring
Series A, $125M raised, Founded 2024
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?